Sign in Pull a receipt

TVRD

Tvardi Therapeutics, Inc.

Healthcare · Biotechnology

$194.36 sample

+1.96 (+1.02%) 1D

Market cap

$446.6B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-27

Alerts

8

Price$194.36 +16.30% 3M daily closessample

194.36166.71

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27SEC8-K filed: material event
Oct 21INSInsider sell: Chief Executive Officer
Oct 14INSInsider sell: EVP, Operations
Oct 08INSInsider sell: Director
Sep 29INSInsider buy: 10% owner
Sep 22INSInsider sell: 10% owner
Sep 14SEC10-Q filed
Sep 03INSInsider sell: EVP, Operations

Sign up to see the real TVRD record →

Company facts

SEC EDGAR registration

Name: Tvardi Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +28sample, -100 to +100
Reporting currency: USD

Who is positioning in TVRD

sample

Insiders: 23 insider transactions over 90 days, net selling, $635.7M
Congress: 2 members traded over 90 days
Institutions · 13F: 34 funds hold $9.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$17.6B +16.1% y/y

Q4 2024Q3 2026

Inventory$10.3B +4.1% y/y

Q4 2024Q3 2026

Accounts receivable$7.8B +8.4% y/y

Q4 2024Q3 2026

Total debt$21.2B +10.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $167.3B +2.7% 3M
Sample peer B: $326.3B -8.4% 3M
Sample peer C: $243.0B -5.0% 3M
Sample peer D: $401.3B +7.0% 3M
Sample peer E: $78.9B +4.7% 3M